Melanoma

Melanoma Clinical Trials Article

Information resource about cancer clinical trials Melanoma Clinical Trials Cancer Information Cancer Center Home Cancer Care and Prevention Professionals Melanoma Trials All Cancer Clinical Trials Learn about the Metastatic Melanoma clinical trial at Novartis and see if you Clinical Trials melanoma clinical trials a list of melanoma clinical trials are posted to the database Many melanoma patients take part in clinical trials often fare better than those who do Results of clinical trials for melanoma and all skin cancer patients Describes causes, diagnosis, and treatment Also shows pictures of different melanoma types and tells how to conduct self skin examinationsIncludes information about research, events, and volunteering, as well as memorials to people who have died of melanomaMultidisciplinary Melanoma Clinic is an internationally recognized resource UMCCC Skin Cancer and Melanoma Clinical Trials in 2006, there will be over 60,000 new cases of melanoma in the United States Melanoma is a cancer of the pigment producing cells in the skin, known as melanocytes Melanoma also runs in families Includes treatment and research news, skin cancer prevention tips, and ocular melanoma informationProviding patients and health care professional with uptodate information on it is so important to catch melanoma early when the cure rate with guide component of this site include: Introductory Information on Melanoma Metastatic Detection Therapy Melanoma Metastasis Clinical Trials Clinical Trials Search Cancer Prevention Studies What is a Clinical Trial? Diseases Clinical Trials FAQ Resource Links

Melanoma Clinical Trials News

CancerVax Resumes Enrollment in Phase 3 Clinical Trials of the CANVAXIN-TM- Therapeutic Cancer Vaccine For Melanoma.

Business Editors/Health/Medical Writers BIOWIRE2K CARLSBAD, CalifBUSINESS WIREApril 15, 2003 FDA Releases CANVAXIN(TM) Vaccine From Partial Clinical Hold CancerVax Corporation announced today that it will resume patient enrollment in its two international Phase 3 clinical trials of the CANVAXIN(TM)

Medarex Initiates Phase II Clinical Trials of MDX-010 for Metastatic Melanoma and Prostate Cancer.

- Enrollment Completed in 2 Phase I/II Melanoma Trials - Medarex, Inc. today announced the initiation of two Phase II clinical trials of MDX-010, one in patients with metastatic melanoma and one in patients with hormone refractory prostate cancer. The two randomized, multi-dose Phase II studies are

CancerVax Completes Planned Enrollment in Phase 3 Clinical Trial of Canvaxin for the Treatment of Stage III Melanoma.

CARLSBAD, Calif. - Phase 3 Trial for Stage IV Melanoma Continues to Enroll Patients CancerVax Corporation (NASDAQ:CNVX) announced today that it has completed the planned enrollment of 1,118 patients into its Phase 3 clinical trial of Canvaxin(TM) for the treatment of patients with Stage III

Oxxon Pharmaccines(TM) Melanoma Therapeutic Vaccine Enters Phase II Clinical Trials.

OXFORD, England - Oxxon Pharmaccines Ltd (Oxxon), a biotechnology company developing innovative immunotherapeutics, specifically therapeutic vaccines (pharmaccines), announced today that its melanoma pharmaccine has moved into Phase II clinical trials in the UK. The Phase I clinical trial

Genzyme Molecular Oncology Announces Initiation of Kidney Cancer and Melanoma Cancer Vaccine Clinical Trials.

Trials for Promising Fusion Cell Technology Expand FRAMINGHAM, Mass., Oct. 3 /PRNewswire/ - Genzyme Molecular Oncology (Nasdaq: GZMO) announced today the initiation of two phase 1-2 clinical trials - one in melanoma and one in kidney cancer - sponsored by investigators Donald Kufe, M.D.,